22.03.2011 • Newsanimal-health industrycooperationIntervet

Merck, Sanofi Cancel Planned Animal-Health JV

Merck & Co and Sanofi-Aventis have terminated their agreement to form a new animal health joint venture. Regarding the reason for the termination, the companies cited the increasing complexity of implementation and the length of time necessary for the worldwide regulatory review process.

Following the termination, each party will keep its current, separate animal health assets and businesses. Merial and Intervet/Schering-Plough will continue to operate independently. The companies added that the termination of the agreement is without penalty and each party is responsible for its own expenses.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.